Biotech giant Vertex Pharmaceuticals has defied the recent marketwide sell-off. The company's shares are up by an impressive 27% since 2025 began. Though it's impossible to tell whether the ...
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
California-based bus manufacturer ENC has partnered with wireless EV charging pioneer InductEV to give transit operators a broader selection of electric bus options, including proven high-power ...
Predictive analytics is a category of advanced data analytics aimed at making predictions about future outcomes based on historical data and analytics techniques such as statistical modeling, data ...
Over in the Bronx, the Charter School for the Arts and Vertex Partnership Academies have been drawing some attention recently, each for very different reasons. The former has partnered with Relay ...
After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...
There is currently no schedule data. The Schedule Release will be available on April.
John Carlini worked for the Ford Motor Company as a carburetor technician in the 1960s. During time trials at Indianapolis in 1965, Jim Clark asked him to clock the qualifying time of his famous Ford.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results